FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gemcitabine Hydrochloride (Gemzar) Lyophilized Powder for Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Eli Lilly and Co. (New 06/11/2018)

Company Contact Information:
800-545-5979

Presentation Posting Date Related Information
Gemzar 200mg/5ml (NDC 0002-7501-01) 06/11/2018 Discontinuation of the manufacture of the drug. The product distribution will continue until end of December 2018.
Gemzar 1g/25ml (NDC 0002-7502-01) 06/11/2018 Discontinuation of the manufacture of the drug. The product distribution will continue until end of December 2018.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English